» Articles » PMID: 8432883

Cathepsin B Expression in Tumour Cells and Laminin Distribution in Pulmonary Adenocarcinoma

Overview
Journal J Clin Pathol
Specialty Pathology
Date 1993 Jan 1
PMID 8432883
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To determine the correlation between cathepsin B expression and laminin distribution in pulmonary adenocarcinoma tissue.

Methods: The distribution of cathepsin B and laminin was examined in 28 formalin fixed, paraffin wax embedded specimens of pulmonary adenocarcinoma tissue, using a double immunostaining technique with commercially available antibodies to cathepsin B and laminin, respectively.

Results: Tumour cells in 23 (82%) cases reacted to cathepsin B: 13 cases were weakly positive and 10 were strongly positive. Laminin in tumour associated basement membrane produced various staining patterns: two cases had an almost continuous distribution of laminin in tumour associated basement membrane in the tumour tissues, while a moderately discontinuous laminin distribution pattern was found in 12 cases, and a highly fragmented pattern was found in 14 cases. The degree of cathepsin B expression in tumour cells was significantly correlated with the break up of laminin staining. In some cases a discontinuous pattern of tumour associated laminin was frequently observed adjacent to cathepsin B positive tumour cell nests.

Conclusions: Considering that cathepsin B has the capacity to degrade basement membrane components, including laminin, the inverse correlation shown in this study between the increase in cathepsin B expression by tumour cells and the diminution of laminin in tumour associated basement membrane could reflect local progression and spread by pulmonary adenocarcinoma.

Citing Articles

Proteogenomic Characterization Reveals Therapeutic Vulnerabilities in Lung Adenocarcinoma.

Gillette M, Satpathy S, Cao S, Dhanasekaran S, Vasaikar S, Krug K Cell. 2020; 182(1):200-225.e35.

PMID: 32649874 PMC: 7373300. DOI: 10.1016/j.cell.2020.06.013.


Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.

Werle B, Lotterle H, Schanzenbacher U, Lah T, Kalman E, Kayser K Br J Cancer. 1999; 81(3):510-9.

PMID: 10507778 PMC: 2362911. DOI: 10.1038/sj.bjc.6690723.


Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines.

Heidtmann H, Salge U, Abrahamson M, Bencina M, Kastelic L, Kopitar-Jerala N Clin Exp Metastasis. 1997; 15(4):368-81.

PMID: 9219725 DOI: 10.1023/a:1018494020001.


Relationship between morphological diversity and AgNORs or cathepsin B expression in colorectal cancers.

Nanashima A, Tagawa Y, Nakagoe T, Hatano K, Uchikawa T, Matsumoto Y J Gastroenterol. 1996; 31(5):646-53.

PMID: 8887029 DOI: 10.1007/BF02347611.

References
1.
Poole A, Tiltman K, Recklies A, Stoker T . Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature. 1978; 273(5663):545-7. DOI: 10.1038/273545a0. View

2.
Starkey J . Cell-matrix interactions during tumor invasion. Cancer Metastasis Rev. 1990; 9(2):113-23. DOI: 10.1007/BF00046338. View

3.
Sloane B, Honn K, Sadler J, Turner W, Kimpson J, Taylor J . Cathepsin B activity in B16 melanoma cells: a possible marker for metastatic potential. Cancer Res. 1982; 42(3):980-6. View

4.
Docherty K, Carroll R, Steiner D . Conversion of proinsulin to insulin: involvement of a 31,500 molecular weight thiol protease. Proc Natl Acad Sci U S A. 1982; 79(15):4613-7. PMC: 346725. DOI: 10.1073/pnas.79.15.4613. View

5.
Shuja S, Sheahan K, Murnane M . Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas. Int J Cancer. 1991; 49(3):341-6. DOI: 10.1002/ijc.2910490305. View